Eagle Meds Services
NovoLog (insulin aspart) product image
Available to SourceHuman Prescription DrugDiabetes & Endocrine

Xultophy 100/3.6 (Insulin Degludec and Liraglutide)

100 [iU]/mL / 3.6 mg/mL · Injection Solution
By Novo Nordisk

Insulin Degludec and Liraglutide · Injectable Solution · 3.6 mg/mL · Subcutaneous

NDC
0169-2911
Route
Subcutaneous
Therapeutic class
GLP-1 Receptor Agonist , Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Insulin Analog , Insulin [CS]
Marketing category
BLA

Package sizes

  • 5 SYRINGE, PLASTIC in 1 CARTON (0169-2911-15) / 3 mL in 1 SYRINGE, PLASTICNDC 0169-2911-15Available to Order
Request This Medication

*Expect a reply within 2 business hours with availability and pricing.

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request a quote

Request this medication.

Pick the package size you need and we’ll respond with availability, lot details, dating, and pricing within 2 business hours. Mark it as Rush or Emergency if you need it faster.

  • DSCSA-compliant pedigree on every order
  • Cold-chain capable where applicable
  • Same-day fulfillment available for urgent needs
Requesting
Xultophy 100/3.6 (Insulin Degludec and Liraglutide)
NDC 0169-2911